Please check your internet connection and try again.
# Urimax (Tamsulosin)
## Overview
Tamsulosin is a selective α1-adrenoceptor antagonist that preferentially binds to α1A receptors in the prostate and bladder neck, causing smooth muscle relaxation and improved urinary flow.
## Primary Indications
* Treatment of signs and symptoms of Benign Prostatic Hyperplasia (BPH).
* Off-label: Medical expulsive therapy (MET) for distal ureteral calculi (nephrolithiasis).
## Adult Dosing
* **BPH:** 0.4 mg orally once daily. May increase to 0.8 mg daily if no response after 2–4 weeks.
* **Nephrolithiasis (Off-label):** 0.4 mg orally once daily.
* **Maximum Dose:** 0.8 mg daily.
## Pediatric Dosing
* **Not indicated.** Safety and efficacy have not been established in children. Use is strictly off-label for specific urological conditions under specialist supervision; dosing varies by local protocol and weight.
## Dose Adjustments
* **Renal Impairment:** No dosage adjustment typically required.
* **Hepatic Impairment:** No specific guidelines; caution in severe impairment as it is extensively metabolized by the liver.
* **CYP3A4/2D6 Inhibitors:** Use caution; dose may need adjustment or therapy paused depending on inhibitor strength.
## Contraindications
* Known hypersensitivity to tamsulosin or any component of the formulation.
* History of angioedema.
## Adverse Effects
* **Common:** Dizziness, headache, abnormal ejaculation (retrograde ejaculation), rhinitis, asthenia.
* **Serious:** Orthostatic hypotension (syncope), priapism, Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery.
## Key Drug Interactions
* **Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin):** Increase tamsulosin exposure; monitor closely.
* **PDE-5 Inhibitors (e.g., sildenafil, tadalafil):** Increases risk of symptomatic hypotension.
* **Antihypertensives:** May cause additive hypotensive effects; monitor blood pressure.
## Monitoring
* Monitor for symptomatic hypotension (particularly after the first dose or dose escalation).
* Monitor BPH symptom scores (e.g., IPSS) to assess efficacy.
* Screen for cataract history before surgery; alert ophthalmologist of current or past tamsulosin use.
## Clinical Pearls
* **Administration:** Take 30 minutes after the same meal each day to ensure consistent bioavailability. Swallow capsules whole; avoid crushing or chewing to prevent dose dumping.
* **IFIS Risk:** Tamsulosin is strongly associated with IFIS. Patients scheduled for cataract surgery should consult their ophthalmologist regarding potential suspension of the drug.
* **Syncope:** Advise patients to rise slowly from a sitting or lying position to mitigate orthostatic symptoms.
***
**Educational Disclaimer:** This summary is for informational purposes only. Clinical practice and dosing protocols can vary significantly by region and institutional policy. Always cross-reference this information with the most current official prescribing information (package insert) and local formulary guidelines before prescribing or administering medication.
